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OBJECTIVES: Certain aspects of pulmonary pathology observed in autopsies of HIV/AIDS patients are still unknown. This study 
considers 250 autopsies of HIV/AIDS patients who died of acute respiratory failure and describes the demographic data, etiology, 
and histological pulmonary findings of the various pathologies. 
METHODS: The following data were obtained: age, sex, and major associated diseases (found at the autopsy). Pulmonary histopa-
thology was categorized as: diffuse alveolar damage; pulmonary edema; alveolar hemorrhage; and acute interstitial pneumonia. Odds 
ratio of the HIV/AIDS-associated diseases developing a specific histopathological pattern was determined by logistic regression. 
RESULTS: A total of 197 men and 53 women were studied. The mean age was 36 years. Bacterial bronchopneumonia was present 
in 36% (91 cases) and Pneumocystis jiroveci pneumonia in 27% (68) of patients. Pulmonary histopathology showed acute interstitial 
pneumonia in 40% (99), diffuse alveolar damage in 36% (89), pulmonary edema in 13% (33), and alveolar hemorrhage in 12% 
(29) of patients. Multivariate analysis showed a significant and positive association between Pneumocystis jiroveci pneumonia 
and acute interstitial pneumonia (Odds ratio, 4.51; 95% CI, 2.46 – 8.24; p < 0.001), severe sepsis and/or septic shock and diffuse 
alveolar damage (Odds ratio, 3.60; 95% CI, 1.78 -7.27; p < 0.001), and cytomegalovirus and acute interstitial pneumonia (Odds 
ratio, 2.22; 95% CI, 1.01 – 4.93; p = 0.05). 
CONCLUSIONS: This report is the first autopsy study to include demographic data, etiologic diagnosis, and respective histopatho-
logical findings in patients with HIV/AIDS and acute respiratory failure. Further studies are necessary to elucidate the complete 
pulmonary physiopathological mechanism involved with each HIV/AIDS-associated disease.
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INTRODUCTION
Millions of people worldwide are infected with the 
human immunodeficiency virus (HIV); moreover, acquired 
immunodeficiency syndrome (AIDS) has become the leading 
cause of death among individuals between the ages of 25 and 
44 years in the United States.1 Patients with HIV/AIDS often 
times have other infectious and non-infectious diseases.2 
Despite the use of prophylactic antibiotics over the course 
of infection, the lungs are the organ most frequently affected 
by HIV/AIDS and, hence, failure of the respiratory system 
is one of the main causes of death in HIV/AIDS patients.2 
Little is known about the causes of death or the histological 
pulmonary findings in patients with HIV/AIDS at autopsy.
We performed a retrospective study of 250 autopsies on 
patients with HIV/AIDS whose cause of death was acute 
respiratory failure (ARF) in order to better describe the 
demographic data and etiological and histological pulmonary 
findings for different HIV/AIDS-associated pathologies.
MATERIAL AND METHODS 
Autopsies
The present study was carried out at a tertiary complex 
center. From 1990 to 2000, 18,899 medical autopsies were 
performed. Histological pulmonary analysis was performed 
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in all cases. The clinical data from patients enrolled in the 
study were reviewed and autopsies were performed with 
legal permission, after informed consent was obtained from a 
family member and after the approval of the Internal Review 
Boards. In this study, we reviewed all available microscopic 
tissue, macroscopic diagnosis of death at autopsy, and 
medical records of the patients included.
ARF was the cause of death in 3,030 (16%) patients. The 
diagnosis of HIV/AIDS was made in 353 (11.5%) of those 
patients. We excluded patients younger than one year of age, 
those without ARF and/or without HIV/AIDS, and 103 cases 
where the histological findings could not be reviewed beause 
the pulmonary tissue was not available.
We also obtained data regarding each patient’s age, sex, 
and major underlying associated diseases (as determined at 
autopsy).
After a complete review, pulmonary pathological reports 
were categorized as: 
•	 Diffuse	 alveolar	 damage	 (DAD):	 diffuse	 involvement	
and uniform temporal appearance of alveolar collapse, 
hyaline membranes, obliterative fibrosis, neo-septa for-
mation, and moderately organizing fibrosis
•	 Pulmonary	edema	(PE):	accumulation	of	proteinaceous	
fluid in the alveolar spaces, giving the appearance of a 
granular, pink coagulate within such spaces
•	 Alveolar	 hemorrhage	 (AH):	 presence	 of	 blood	 in	 the	
alveolar spaces
•	 Acute	interstitial	pneumonia	(AIP):	widened	and	edema-
tous alveolar septa, usually accompanied by mononuclear 
inflammatory infiltrate of lymphocytes, histiocytes, 
plasma cells, and neutrophils.
All lungs were analyzed by microscopy even when 
medical records indicated the patient’s diagnosis. For at least 
four weeks, the lungs were fixed in 10% formalin prepared 
in 0.9% saline. We studied a minimum of five sections per 
lung (total ten sections per person) regardless of the presence 
or absence of morphologically demonstrable lesions. 
Paraffin-embedded tissue sections were assessed following 
haematoxylin and eosin staining. In order to document the 
presence and distribution of the wide spectrum of infectious 
agents to which this population is susceptible, we prepared 
a variety of special stains (Periodic acid-Schiff test, 
immunohistochemistry analysis, fluorescence, Ziehl-Neelsen, 
Gram, Mucicarmine, and Gomori’s methenamine silver stain) 
for selected tissue sections. Bacterial bronchopneumonia 
(BBP) was defined as the presence of cell consolidation with 
polymorphonuclear leukocyte accumulation in bronchioles 
and adjacent alveoli. For the diagnosis of cytomegalovirus 
(CMV) and fungal pneumonia, histological evidence of 
lung involvement was required with or without tissue 
culture. Severe sepsis and/or septic shock were defined as 
sepsis with the addition of organ dysfunction or clinical 
diagnosis of arterial hypotension, which may or may not be 
responsible for the aggressive fluid resuscitation. Diagnosis 
of Mycobacterium tuberculosis infection and atypical 
mycobacterial infection was confirmed using fluorescence 
and Ziehl-Neelsen techniques, and Lowenstein-Jensen 
culture. The proportion method and biochemistry were used 
for identification of all positive cultures.
Statistical analysis
Descriptive analysis of the data included median, 
minimum, and maximum values. The probability (odds ratio) 
that the major AIDS-associated diseases would develop a 
specific histopathological pattern was determined by logistic 
regression. All the statistical procedures were performed 
using SPSS v10.0 statistical software. Statistical significance 
was set at 5% (p value). 
RESULTS
HIV/AIDS was described in 353 autopsies (11.65% of 
all patients with ARF); we analyzed 250 of these cases. The 
demographic data are listed in Table 1. A total of 197 (79%) 
HIV/AIDS-infected men and 53 (21%) HIV/AIDS-infected 
women were included in the study. The age at the time of 
death was 21 to 40 years (161 patients) for most cases. The 
diagnosis of HIV/AIDS showed relatively annual variation 
between the years 1990 and 2000.
We observed a single HIV/AIDS-associated disease 
in 101 (40%) cases, two diseases in 67 (27%) cases, three 
diseases in 31 (12%) cases, and four diseases in 9 (4%) 
cases. No HIV/AIDS-associated diseases were detected in 
40 patients (16%).
The HIV/AIDS-associated diseases in patients with 
ARF are shown in Table 2. BBP was present in 36% of 
patients (91 cases) and was the most frequent pulmonary 
complication found at the time of autopsy. Pneumocystis 
Table 1 - Demographic analysis by sex and age in the autop-
sies of patients with HIV/AIDS
Age group (years)
Sex
Male Female Total
1 to 20 10 5 15 (6%)
21 to 40 126 35 161 (64%)
41 to 60 57 11 68 (27%)
>60 4 2 6 (3%)
Total 197 (79%) 53 (21%) 250
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jiroveci pneumonia (PJP) was the second most frequent, 
observed in 27% of patients (68 cases), followed by 
severe sepsis and/or septic shock in 14% of patients (34 
cases), CMV in 13% of patients (33 cases), disseminated 
tuberculosis in 8% of patients (19 cases), toxoplasmosis in 
7% of patients (18 cases), and pulmonary tuberculosis in 7% 
of patients (17 cases).
The pulmonary histopathological analysis showed AIP in 
40% of patients (99 patients), DAD in 36% of patients (89 
patients), PE in 13% of patients (33 patients), and AH in 12% 
of patients (29 patients). The pulmonary histopathological 
findings observed in different HIV/AIDS-associated diseases 
are shown in Table 2. 
Multivariate analysis (Table 3) demonstrated a 
statistically significant association between BBP and DAD 
(odds ratio [OR], 0.54; 95% confidence interval [CI], 0.31 
Table 2 - Etiological diagnoses observed in autopsies of HIV/AIDS patients who died by ARF, along with the cause of death 
and main pulmonary histopathological findings
Disease DAD PE AH AIP Total
Bacterial bronchopneumonia 31 15 17 28 91
Pneumocystis jiroveci pneumonia 16 2 5 45 68
Severe sepsis and/or shock septic 21 2 4 7 34
Cytomegalovirus 8 1 4 20 33
Disseminated tuberculosis 12 3 2 2 19
Toxoplasmosis 7 4 2 5 18
Pulmonary tuberculosis 8 2 3 4 17
Atypical mycobacterial infection 9 4 0 2 15
Kaposi sarcoma 3 1 3 4 11
Pulmonary embolism 5 2 0 3 10
Neurocryptococosis 3 1 0 3 7
Non-Hodgkin’s lymphoma 2 2 0 1 5
Bacterial meningitis 1 0 3 0 4
Lymphoma* 2 0 0 2 4
Histoplasmosis 3 0 0 0 3
Urinary tract infection 2 0 0 1 3
Hepatic cirrhosis* 1 1 0 1 3
Schistosomosis 3 0 0 0 3
Acute Peritonitis* 2 0 0 1 3
Acute bacterial endocarditis 2 0 0 0 2
Pulmonary cryptococcosis 0 1 1 0 2
Neurocysticercosis 1 0 0 1 2
Chronic pneumopathy* 0 1 0 0 1
Pyelonephritis 0 0 0 1 1
Disseminated malignant neoplasm* 1 0 0 0 1
Neuropathy* 1 0 0 0 1
Duodenal ulcer 1 0 0 0 1
Acute renal failure 1 0 0 0 1
Chronic pancreatitis 0 0 0 1 1
HCB 1 0 0 0 1
Spelling 1 0 0 0 1
Venous profound thrombosis 1 0 0 0 1
Aspergillosis 0 0 1 0 1
* = No cause identified; HCB = Hepatitis virus B; DAD = Diffuse alveolar damage; PE = Pulmonary edema; AH = Alveolar hemorrhage; AIP =Acute 
interstitial pneumonia. 
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– 0.94; p = 0.03), BBP and AIP (OR, 0.52; 95% CI, 0.29 
– 0.91; p = 0.02), PJP and AIP (OR, 4.51; 95% CI, 2.46 – 
8.24; p < 0.001), severe sepsis and/or septic shock and DAD 
(OR, 3.60; 95% CI, 1.78 -7.27; p < 0.001), CMV and AIP 
(OR, 2.22; 95% CI, 1.01 – 4.93; p = 0.05), and disseminated 
tuberculosis and AIP (OR, 0.14; 95% CI, 0.03 – 0.63; p = 
0.01).
DISCUSSION
This is the first report of an autopsy study that includes 
the demographic data, etiologic diagnosis, and respective 
histopathological findings in patients with HIV/AIDS and 
acute respiratory failure. HIV/AIDS was described in 250 
autopsies. As described, BBP was present in 36% and PJP 
in 27% of patients. Pulmonary histopathology showed acute 
interstitial pneumonia in 40%, diffuse alveolar damage in 
36%, pulmonary edema in 13%, and alveolar hemorrhage in 
12% of patients. Multivariate analysis showed a significant 
and positive association between PJP and acute interstitial 
pneumonia, severe sepsis and/or septic shock and diffuse 
alveolar damage, and finally cytomegalovirus and acute 
interstitial pneumonia. 
The accurate diagnosis and early treatment of HIV/
AIDS-associated diseases remain important problems in 
the management of patients with HIV/AIDS.2 Pulmonary 
involvement has been reported in 80 – 94% of patients with 
HIV/AIDS-associated diseases.2 Despite recent technological 
advances in diagnosis, the autopsy has remained an important 
complementary tool for the identification and understanding 
of diseases in patients with HIV/AIDS.1 Recent autopsy 
studies have shown important differences between autopsy 
findings and the clinical diagnosis antemortem.1-3 In the 
present study, we observed a high prevalence (16%) of 
patients with HIV/AIDS who also had ARF as the cause of 
death. Most analyzed patients were males (79%); the mean 
age was 36 years. Studies in other countries have shown 
similar data.1,4 A retrospective study carried out between 
1988 and 2000 considered 143 autopsies of patients with 
HIV/AIDS in India; this study showed a prevalence of HIV/
AIDS of 72% in men and 48% in patients 21 to 30 years 
old.2
In the present study, the diagnosis of HIV/AIDS showed 
relatively little annual variation between the years 1990 and 
2000. The beginning of the study was characterized by the 
greatest number of cases, which then progressively decreased 
and finally showed a small, transient increase. This variation 
was probably due to the decrease in the incidence of HIV/
AIDS, better efficacy and distribution of antiretroviral 
therapy, and recent technological advances in diagnosis.
We observed a single HIV/AIDS-associated disease in 
101 (40%) cases, and two or more HIV/AIDS-associated 
diseases in 44% of patients. In an autopsy study of patients 
with HIV/AIDS performed in the United States, Afessa et al. 
showed the presence of two or more associated diagnoses in 
52% of the cases studied.1 Hence, an important association 
Table 3. Multivariate analysis with the main associated diseases found in autopsies of HIV/AIDS patients, and their relation-
ship with the respective pulmonary histopathological findings
Diseases
Pulmonary histopathological findings
DAD PE AH AIP
p* OR CI 95% p* OR CI 95% p* OR CI 95% p* OR CI 95%
Bacterial bronchopneumonia 0.03 0.54 0.31 – 0.94 NS 0.91 0.42 - 1.98 NS 1.85 0.78 - 4.37 0.02 0.52 0.29 - 0.91
Pneumocystis jiroveci pneu-
monia
NS 0.6 0.31 - 1.17 0.05 0.28 0.05 - 1.01 NS 0.79 0.27 - 2.33 <0.001 4.51 2.46 - 8.24
Severe sepsis and/or shock 
septic
<0.001 3.6 1.78 - 7.27 NS 0.38 0.08 - 1.76 NS 1.36 0.43 - 4.29 NS 0.53 0.20 - 1.36
Cytomegalovirus NS 0.95 0.39 - 2.31 NS 0.32 0.04 - 2.51 NS 1.63 0.50 - 5.29 0.05 2.22 1.01 - 4.93
Disseminated tuberculosis NS 2.1 0.91 - 4.87 NS 1.18 0.32 - 4.41 NS 0.94 0.20 - 4.42 0.01 0.14 0.03 - 0.63
Toxoplasmosis NS 0.78 0.3 - 2.02 NS 1.74 0.54 - 5.56 NS 1.03 0.22 - 4.80 NS 0.42 0.14 - 1.25
Pulmonary tuberculosis NS 1.59 0.63 - 4.03 NS 0.88 0.19 - 4.09 NS 1.37 0.36 - 5.19 NS 0.43 0.13 - 1.41
Atypical mycobacterial infec-
tion
NS 2.61 0.94 - 7.27 NS 3.18 0.89 - 11.31 NS 0.001 0 - 3.8 NS 0.33 0.07 - 1.56
Kaposi sarcoma NS 0.74 0.20 - 2.77 NS 0.65 0.08 - 5.31 NS 2.77 0.72 - 10.72 NS 0.76 0.22 - 2.64
Pulmonary embolism NS 1.73 0.54 - 5.52 NS 1.49 0.31 - 7.24 NS 0.001 0.001 - 6.0 NS 0.63 0.15 - 2.54
OR = Odds ratio; CI = Confidence interval; DAD = Diffuse alveolar damage; PE = Pulmonary edema; AH = Alveolar hemorrhage; AIP = Acute intersti-
tial pneumonia; NS = Not statistically significant. *p < 0.05
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between different pulmonary diseases in patients with HIV/
AIDS and ARF was established, which could indicate 
the necessity of a different therapeutic strategy for these 
patients.
BBP was present in 36% of the patients (91 cases) and it 
was the most frequent pulmonary complication found during 
autopsy. The importance of BBP was not fully recognized in the 
beginning of the HIV/AIDS epidemic. However, recent studies 
have shown that bacterial infections occur more frequently than 
other opportunistic infections in patients with HIV/AIDS.1,4-7 
The occurrence of bacterial infections in patients with HIV/
AIDS is also a reflection of their immunosuppression, and 
the most frequent pathogens are Streptococcus pneumoniae, 
Staphylococcus aureus, Haemophilus influenzae, and 
Pseudomonas aeruginosa.1-5 Rana et al. analyzed autopsies 
in Kenya and showed an association between tuberculosis and 
BBP in 96% of patients with HIV/AIDS.6 Even in pediatrics 
studies, BBP appeared as the major cause of ARF in autopsies 
of patients with HIV/AIDS.5
At the onset of the HIV/AIDS epidemic, PJP was 
the most common pulmonary opportunistic infection in 
developed countries, although recent advances in early 
detection, primary and secondary prophylaxis, and the 
aggressive treatment of PJP have resulted in a decline in 
prevalence.2 The involvement of PJP in pulmonary infection 
has been reported in 5 – 24% of cases.1-4,8-10 In the present 
study, the prevalence of PJP was 27%, which is different 
from that found in developing countries, where tuberculosis 
is the most prevalent opportunistic infection in patients 
with HIV/AIDS.1-4,8-10 We believe that the high prevalence 
of PJP in our study may be due to variable distribution in 
our country. Morris et al. used polymerase chain reaction 
(PCR) to detect the presence of Pneumocystis in autopsies 
of patients with HIV/AIDS; the rate of Pneumocystis 
colonization was 46%, although the infection levels were 
lower.11
Several autopsy studies in patients with HIV/AIDS have 
reported the presence of CMV infection in 7 – 81% of patient 
cases.2,4,9,10,12-16 In the present study, CMV pneumonitis 
was found in 13% of patients. CMV infection has been 
clinically undiagnosed and, thus, it has shown an important 
discrepancy with autopsy results.2 In a study carried out in 
India, Lanjewar et al. detected CMV in 7% of cases.2 Ohtomo 
et al. conducted an autopsy study in Japan between 1986 and 
1997 and found that CMV infections, present in 32% of 
cases, were the major opportunistic infection in patients with 
HIV/AIDS.9 Similar findings were reported by McKenzie et 
al., but with a higher rate of infection (81%).10
Tuberculosis was found in 15% of the cases in our study 
(8% as the disseminated form and 7% as the pulmonary 
form). To date, autopsy studies have found the presence of 
Mycobacterium tuberculosis infection in 5 – 59% of cases.
(2,5,6,8,9,17-19) In developed countries such as Italy and Japan, 
the prevalence of tuberculosis in autopsies of patients with 
HIV/AIDS is 5 – 7%, whereas these rates were found to be 
40 – 59% in developing countries, markedly different from 
the values observed in our study.2,5,6,8,9,17-19 One of the most 
common characteristics of tuberculosis is its chronic form of 
development and progression, which justify the lower rates 
observed in the present study, where only patients with ARF 
were studied. 
The etiological diagnosis, such as atypical mycobacterial 
infection and Kaposi’s sarcoma, also showed an important 
prevalence in our study. Atypical mycobacterial infection 
was present in 6% of cases. As with tuberculosis, we 
observed lower levels than those found in the literature (15 
– 33%), probably due to the fact that only patients with ARF 
were studied.1,4,10,17 Kaposi’s sarcoma, present in 4.5% of 
cases, was the most common malignancy affecting patients 
with HIV/AIDS. A similar prevalence (1 – 11%) has been 
reported in other autopsy studies of patients with HIV/
AIDS.2,5,8-10,13,16 
Based upon pulmonary histopathological analysis, AIP 
was the most common pattern observed (40% of cases), 
followed by DAD (36% of cases). No similar data were 
found in the literature regarding the autopsies of patients 
with HIV/AIDS. However, these findings are in agreement 
with the higher prevalence of opportunistic infections, 
mainly viral, fungal, and mycobacterial infections, which 
frequently cause the development of AIP. Other contributing 
factors include the impeded mechanical ventilation, which 
could accelerate the development of these histopathologies. 
The microscopic analysis showed that the alveolar septa 
were widened and edematous; furthermore, they presented 
with a mononuclear inflammatory infiltrate of lymphocytes, 
histiocytes, plasma cells, and neutrophils. The association 
between PJC and CMV with AIP was also observed. 
Notably, a negative association was observed between 
BBP and DAD, disseminated tuberculosis and AIP, and 
also BBP and AIP. We had expected a positive association 
between these factors, but we observed that the acute 
inflammatory pattern was extensively modified, probably 
due to immunosuppression. Some studies have proposed the 
presence of cell atypias, immunosuppression, antiretroviral 
therapy, antibiotics, and opportunistic infections as the main 
modifiers of the inflammatory response in patients with HIV/
AIDS and bacterial infections.20,21 
CONCLUSIONS
Despite recent technological advances in diagnosis, the 
autopsy has remained an important complementary tool for 
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the identification and understanding of diseases in patients 
with HIV/AIDS. The lungs are the most commonly affected 
organ in patients with HIV/AIDS. BBP was the most 
common diagnosis, followed by PJC. The most prevalent 
pulmonary histopathological pattern was AIP, which 
suggested a positive association between PJC and CMV.
Further studies are necessary to elucidate the complete 
pulmonary physiopathological mechanism involved with 
each AIDS-associated disease. 
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